Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Juul Loland

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|May 30, 2003
Evidence for distinct sodium-, dopamine-, and cocaine-dependent conformational changes in transmembrane segments 7 and 8 of the dopamine transporterLene Norregaard, Claus Juul Loland, Ulrik Gether
European Journal of Pharmacology|November 13, 2003
Probing dopamine transporter structure and function by Zn2+-site engineeringClaus Juul Loland, Kristine Norgaard-Nielsen, Ulrik Gether
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2002
Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycleClaus Juul Loland, Lene Norregaard, Thomas Litman, et al.
The Journal of Biological Chemistry|November 5, 2003
Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine bindingClaus Juul Loland, Charlotta Grånäs, Jonathan A Javitch, et al.
Neuropharmacology|November 26, 2019
Special issue on neurotransmitter transportersFarrukh Abbas Chaudhry, Claus Juul Loland, Arturo Ortega, et al.
Trends in Pharmacological Sciences|May 31, 2020
Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic StrategyMarco Niello, Ralph Gradisch, Claus Juul Loland, et al.
Cells|December 11, 2022
Pharmacological Characterization of Purified Full-Length Dopamine Transporter from <i>Drosophila melanogaster</i>Ciara Frances Pugh, Brian Thomas DeVree, Solveig Gaarde Schmidt, et al.
The Journal of Biological Chemistry|December 5, 2002
N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalizationCharlotta Granas, Jasmine Ferrer, Claus Juul Loland, et al.
Neuropharmacology|September 1, 2005
Intramolecular cross-linking in a bacterial homolog of mammalian SLC6 neurotransmitter transporters suggests an evolutionary conserved role of transmembrane segments 7 and 8Julie Kniazeff, Claus Juul Loland, Naomi Goldberg, et al.
Journal of Medicinal Chemistry|November 19, 2013
Design and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sitesAshwini K Banala, Peng Zhang, Per Plenge, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|May 30, 2003
Evidence for distinct sodium-, dopamine-, and cocaine-dependent conformational changes in transmembrane segments 7 and 8 of the dopamine transporterLene Norregaard, Claus Juul Loland, Ulrik Gether
European Journal of Pharmacology|November 13, 2003
Probing dopamine transporter structure and function by Zn2+-site engineeringClaus Juul Loland, Kristine Norgaard-Nielsen, Ulrik Gether
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2002
Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycleClaus Juul Loland, Lene Norregaard, Thomas Litman, et al.
The Journal of Biological Chemistry|November 5, 2003
Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine bindingClaus Juul Loland, Charlotta Grånäs, Jonathan A Javitch, et al.
Neuropharmacology|November 26, 2019
Special issue on neurotransmitter transportersFarrukh Abbas Chaudhry, Claus Juul Loland, Arturo Ortega, et al.
Trends in Pharmacological Sciences|May 31, 2020
Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic StrategyMarco Niello, Ralph Gradisch, Claus Juul Loland, et al.
Cells|December 11, 2022
Pharmacological Characterization of Purified Full-Length Dopamine Transporter from <i>Drosophila melanogaster</i>Ciara Frances Pugh, Brian Thomas DeVree, Solveig Gaarde Schmidt, et al.
The Journal of Biological Chemistry|December 5, 2002
N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalizationCharlotta Granas, Jasmine Ferrer, Claus Juul Loland, et al.
Neuropharmacology|September 1, 2005
Intramolecular cross-linking in a bacterial homolog of mammalian SLC6 neurotransmitter transporters suggests an evolutionary conserved role of transmembrane segments 7 and 8Julie Kniazeff, Claus Juul Loland, Naomi Goldberg, et al.
Journal of Medicinal Chemistry|November 19, 2013
Design and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sitesAshwini K Banala, Peng Zhang, Per Plenge, et al.
Pageof 2